A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients

This study has been completed.

Study NCT00787891 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: November 6, 2008 Last Updated: July 14, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2011
Primary Completion Date:	January 2011 (Final data collection date for primary outcome measure)